Key Insights

Highlights

Success Rate

50% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 55/100

Termination Rate

42.9%

3 terminated out of 7 trials

Success Rate

50.0%

-36.5% vs benchmark

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

133%

4 of 3 completed with results

Key Signals

4 with results50% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (3)
P 2 (1)
P 3 (1)
P 4 (1)

Trial Status

Terminated3
Completed3
Recruiting1

Trial Success Rate

50.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (7)

Research Network

Activity Timeline